Pubblicazioni

Major Depression in Comorbidity with Substance use Disorders: Patientsâ Features and Clinical-Neurobiological Rationale of Antidepressant Treatments

2024 - CURRENT NEUROPHARMACOLOGY

DE FILIPPIS, Sergio; Martinotti, Giovanni; Nicoletti, Ferdinando; Mastrostefano, Andrea; Trovini, Giada; Pugliese, Anna; Di Nicola, Marco

Disease-Modifying Symptomatic Treatment (DMST): The Potential Role of Vortioxetine in the Treatment of Depression in Patients with Multiple Sclerosis

2024 - CURRENT NEUROPHARMACOLOGY

Dolcetti, Ettore; Annovazzi, Pietro; Clerico, Marinella; Cocco, Eleonora; Conte, Antonella; Marfia, Girolama Alessandra; Salvetti, Marco; Tomassini, Valentina; Clerici, Valentina Torri; Totaro, Rocco; Bruno, Antonio; Centonze, Diego

Monoamine-Oxidase type B- Inhibitors and Cognitive Functions in Parkinson's Disease: Beyond the Primary Mechanism of Action

2022 - CURRENT NEUROPHARMACOLOGY

Rinaldi, Domiziana; Alborghetti, Marika; Bianchini, Edoardo; Sforza, Michela; Galli, Silvia; Pontieri, Francesco E

BDNF and its Role in the Alcohol Abuse Initiated During Early Adolescence: Evidence from Preclinical and Clinical Studies

2022 - CURRENT NEUROPHARMACOLOGY

Cutuli, Debora; Sampedro-Piquero, Piquero

Highlighting the role of cognitive and brain reserve in the substance use disorder field

2019 - CURRENT NEUROPHARMACOLOGY

Cutuli, D.; Ladron de Guevara-Miranda, D.; Castilla-Ortega, E.; Santin, L. J.; Sampedro-Piquero, P.